4 of 50
BACKNEXT
Johnson & Johnson
Johnson & Johnson
MOST ADMIRED
Top 50 rank: 4
Rank in Pharmaceuticals: 2
(Previous rank: 1)
Overall score: 6.67
Why it's admired
Survey respondents cheered J&J's banner year in 2008, which made it one of the most profitable companies in the Fortune 500 (earnings grew 22%, while the Fortune 500's profits dropped 85%). They also celebrated its stock performance the past few years, when the health-care giant consistently beat the S&P.

But the troubled economy brought sluggish sales last year, and J&J was forced to lay off 7,000 employees in November.

Even so, thanks to continued innovation and an overhaul of its pharmaceutical business, the company continued to win admiration. It also rewarded shareholders, increasing dividends as its stock climbed nearly 32% in the past 12 months. --C.T.

Should Johnson & Johnson be admired, or what?
Johnson & Johnson stats
Nine key attributes of reputation Industry rank
Innovation 8
People management 1
Use of corporate assets 2
Social responsibility 1
Quality of management 2
Financial soundness 1
Long-term investment 1
Quality of products/services 5
Global competitiveness 2
From the March 22, 2010 issue
Headquarters
1 Johnson & Johnson Plaza
New Brunswick, NJ 08933
732-524-0400
www.jnj.com
Show: Top 50 | All Most Admired: The Americas | Europe | Asia/Australia
Find companies you most admire
 Innovation  Quality of management
 People management  Financial soundness
 Use of corporate assets  Long-term investment
 Social responsibility  Product/services quality
 Global competitiveness  




Video
The Most Admired list is the definitive report card on corporate reputations. Our survey partners at Hay Group start with about 1,400 companies... More
Current Issue
  • Give the gift of Fortune
  • Get the Fortune app
  • Subscribe
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.